Sinha Uma
Chief Scientific Officer at Eidos Therapeutics, Inc.
- Sold, on record
- $3.5M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jan 13, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Eidos Therapeutics, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Eidos Therapeutics, Inc.Plan not statedMay 23, 2019 2019
Sold 5,000 shares at $27.28 ($136k)
Sinha Uma, Chief Scientific Officer
Sold 1.4% of holdings ($9.7M position)349,312 shares leftFirst sale on recordFiling
- 2 Form 4 sale Eidos Therapeutics, Inc.Plan not statedJul 25, 2019 +63 days
Sold 5,000 shares at $36.13 ($181k)
Sinha Uma, Chief Scientific Officer
Sold 1.4% of holdings ($12.7M position)346,081 shares leftFiling
- 3 Form 4 sale Eidos Therapeutics, Inc.Plan not statedSep 25, 2019 +62 days
Sold 2,500 shares at $38.41 ($96k)
Sinha Uma, Chief Scientific Officer
Sold 0.7% of holdings ($13.3M position)343,581 shares leftFiling
- 4 Form 4 sale Eidos Therapeutics, Inc.Plan not statedDec 18, 2019 +84 days
Sold 12,500 shares at $61.90 ($774k)
Sinha Uma, Chief Scientific Officer
Sold 3.6% of holdings ($21.3M position)331,081 shares left2.5x usual sizeFiling
- 5 Form 4 sale Eidos Therapeutics, Inc.Plan not statedOct 1, 2020 +288 days
Sold 5,000 shares at $52.34 ($262k)
Sinha Uma, Chief Scientific Officer
Sold 1.5% of holdings ($17.4M position)326,525 shares left1x usual sizeFiling
- 6 Form 4 sale Eidos Therapeutics, Inc.Plan not statedOct 29, 2020 +28 days
Sold 5,000 shares at $72.42 ($362k)
Sinha Uma, Chief Scientific Officer
Sold 1.5% of holdings ($23.6M position)321,525 shares left1x usual sizeFiling
- 7 Form 4 sale Eidos Therapeutics, Inc.Plan not statedDec 2, 2020 +34 days
Sold 5,000 shares at $90.04 ($450k)
Sinha Uma, Chief Scientific Officer
Sold 1.6% of holdings ($28.9M position)316,525 shares left1x usual sizeFiling
- 8 Form 4 sale Eidos Therapeutics, Inc.Plan not statedJan 13, 2021 +42 days
Sold 10,000 shares at $124.32 ($1.2M)
Sinha Uma, Chief Scientific Officer
Sold 3.2% of holdings ($39.4M position)306,525 shares left2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2021 | Jan 15, 2021 | Eidos Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $1.2M | 3.2% | Plan not stated | SEC |
| Dec 2, 2020 | Dec 4, 2020 | Eidos Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 5,000 | $450k | 1.6% | Plan not stated | SEC |
| Oct 29, 2020 | Oct 30, 2020 | Eidos Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 5,000 | $362k | 1.5% | Plan not stated | SEC |
| Oct 1, 2020 | Oct 2, 2020 | Eidos Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 5,000 | $262k | 1.5% | Plan not stated | SEC |
| Dec 18, 2019 | Dec 20, 2019 | Eidos Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 12,500 | $774k | 3.6% | Plan not stated | SEC |
| Sep 25, 2019 | Sep 27, 2019 | Eidos Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,500 | $96k | 0.7% | Plan not stated | SEC |
| Jul 25, 2019 | Jul 29, 2019 | Eidos Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 5,000 | $181k | 1.4% | Plan not stated | SEC |
| May 23, 2019 | May 28, 2019 | Eidos Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 5,000 | $136k | 1.4% | Plan not stated | SEC |